Marshall S. Flam

3.0k total citations · 1 hit paper
59 papers, 2.2k citations indexed

About

Marshall S. Flam is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marshall S. Flam has authored 59 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 20 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marshall S. Flam's work include Colorectal and Anal Carcinomas (16 papers), Multiple Myeloma Research and Treatments (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Marshall S. Flam is often cited by papers focused on Colorectal and Anal Carcinomas (16 papers), Multiple Myeloma Research and Treatments (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Marshall S. Flam collaborates with scholars based in United States. Marshall S. Flam's co-authors include Madhu J. John, Robert J. Myerson, Thomas F. Pajak, Karl T. K. Chen, Marvin Rotman, Michelle E. St. John, Stephen Doggett, Herbert D. Kerman, Nicholas J. Petrelli and L. Coia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Marshall S. Flam

58 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

1996 754 citations Marshall S. Flam, Michelle E. St. John et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marshall S. Flam United States	23	1.5k	977	704	329	197	59	2.2k
Kamal Abeywickrama Switzerland	13	1.5k 1.0×	194 0.2×	440 0.6×	401 1.2×	182 0.9×	24	2.7k
Efstathios Papalambros Greece	25	748 0.5×	675 0.7×	372 0.5×	178 0.5×	173 0.9×	92	1.6k
Stuart G. Marcus United States	22	614 0.4×	612 0.6×	607 0.9×	95 0.3×	283 1.4×	44	1.5k
Diane Mège France	24	1.1k 0.8×	310 0.3×	1.1k 1.6×	184 0.6×	348 1.8×	115	2.2k
Giovanni Franchin Italy	25	531 0.4×	852 0.9×	646 0.9×	116 0.4×	234 1.2×	109	2.0k
K. J. Roozendaal Netherlands	20	680 0.5×	260 0.3×	381 0.5×	189 0.6×	311 1.6×	40	1.9k
Satvinder Mudan United Kingdom	22	1.8k 1.2×	2.2k 2.2×	1.1k 1.5×	204 0.6×	172 0.9×	90	3.7k
Leif Bostad Norway	24	575 0.4×	821 0.8×	208 0.3×	329 1.0×	477 2.4×	87	2.5k
Matthias Peiper Germany	28	707 0.5×	814 0.8×	823 1.2×	194 0.6×	446 2.3×	117	2.2k
Mary R. Schwartz United States	21	454 0.3×	284 0.3×	416 0.6×	300 0.9×	194 1.0×	83	1.3k

Countries citing papers authored by Marshall S. Flam

Since Specialization

Citations

This map shows the geographic impact of Marshall S. Flam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall S. Flam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall S. Flam more than expected).

Fields of papers citing papers by Marshall S. Flam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marshall S. Flam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall S. Flam. The network helps show where Marshall S. Flam may publish in the future.

Co-authorship network of co-authors of Marshall S. Flam

This figure shows the co-authorship network connecting the top 25 collaborators of Marshall S. Flam. A scholar is included among the top collaborators of Marshall S. Flam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall S. Flam. Marshall S. Flam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berenson, James R., Laura Stampleman, Alberto Bessudo, et al.. (2015). Safety and efficacy of pomalidomide (POM), dexamethasone (DEX), and pegylated liposomal doxorubicin (PLD) for patients with relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. 33(15_suppl). 8591–8591. 2 indexed citations

Yellin, Ori, Chen‐Li Cheng, Alan Cartmell, et al.. (2012). A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma. Leukemia. 26(7). 1675–1680. 32 indexed citations

Berenson, James R., Ori Yellin, Alan Cartmell, et al.. (2010). A Phase II Study of Pegylated Liposomal Doxorubicin (PLD), Bortezomib, Dexamethasone and Lenalidomide (DVD-R) for Patients with Relapsed/Refractory (R/R) Multiple Myeloma (MM). Blood. 116(21). 3044–3044. 2 indexed citations

Berenson, James R., Ori Yellin, Donald Woytowitz, et al.. (2007). Bortezomib, Ascorbic Acid and Melphalan (BAM) Therapy for Patients (pts) with Newly Diagnosed Multiple Myeloma (MM): An Effective and Well-Tolerated Frontline Regimen.. Blood. 110(11). 3602–3602. 8 indexed citations

Boswell, John S., et al.. (2006). Basal cell carcinoma metastatic to cervical lymph nodes and lungs. Dermatology Online Journal. 12(6). 9–9. 17 indexed citations

Berenson, James R., Ralph V. Boccia, David S. Siegel, et al.. (2006). Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single‐arm study. British Journal of Haematology. 135(2). 174–183. 64 indexed citations

Nagourney, Robert Alan, et al.. (2004). Carboplatin & gemcitabine repeating doublet in recurrent breast cancer. Journal of Clinical Oncology. 22(14_suppl). 851–851. 4 indexed citations

Shank, Brenda, Warren E. Enker, & Marshall S. Flam. (2003). Gross and Microscopic Anatomy. PLoS ONE. 12(4). e0175404–e0175404. 1 indexed citations

Flam, Marshall S., et al.. (1998). Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.. PubMed. 4(3). 178–84. 17 indexed citations

10.

Flam, Marshall S., Michelle E. St. John, Thomas F. Pajak, et al.. (1996). Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.. Journal of Clinical Oncology. 14(9). 2527–2539. 754 indexed citations breakdown →

11.

Flam, Marshall S., et al.. (1992). Improved food intake and reduced nausea and vomiting in patients given a restricted diet while receiving cisplatin chemotherapy. Journal of the American Dietetic Association. 92(1). 58–61. 11 indexed citations

12.

John, Madhu J., et al.. (1989). Radiotherapy alone and chemoradiation for nonmetastatic. Cancer. 63(12). 2397–2403. 99 indexed citations

13.

Chen, Karl T. K., Marshall S. Flam, Cynthia J. Curry, & Madhu J. John. (1989). Hodgkinʼs Disease Complicating Neuronal Ceroid-Lipofuscinosis. Journal of Pediatric Hematology/Oncology. 11(1). 51–54. 1 indexed citations

14.

Valone, Frank H., et al.. (1988). A Northern California Oncology Group Randomized Trial of Single Agent 5-FU vs. High-Dose Folinic Acid + 5-FU vs. Methotrexate + 5-FU + Folinic Acid in Patients with Disseminated Measurable Large Bowel Cancer. Advances in experimental medicine and biology. 244. 193–199. 5 indexed citations

15.

John, Madhu J., et al.. (1987). Inoperable Esophageal Carcinoma. American Journal of Clinical Oncology. 10(4). 310–316. 12 indexed citations

16.

Flam, Marshall S., et al.. (1987). Definitive combined modality therapy of carcinoma of the anus. Diseases of the Colon & Rectum. 30(7). 495–502. 66 indexed citations

17.

McCarty, James, et al.. (1986). Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. The Journal of Pediatrics. 108(5). 721–724. 60 indexed citations

18.

Flam, Marshall S., et al.. (1983). Definitive nonsurgical therapy of epithelial malignancies of the anal canal a report of 12 cases. Cancer. 51(8). 1378–1387. 41 indexed citations

19.

Chen, Karl T. K., et al.. (1983). Carcinosarcoma of renal pelvis. Urology. 22(4). 429–431. 15 indexed citations

20.

Flam, Marshall S., et al.. (1982). Hodgkin's disease involving the urinary bladder diagnosed by urinary cytology. A case report. Cancer. 50(11). 2482–2485. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact